Cocrystal Pharma (COCP) Current Assets (2010 - 2026)

Cocrystal Pharma (COCP) has 16 years of Current Assets data on file, last reported at $5.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 32.71% year-over-year to $5.9 million; the trailing twelve-month figure through Mar 2026 stood at $5.9 million (down 32.71% YoY), and the FY2025 full-year result was $8.1 million, down 29.76% from the prior year.
• Current Assets fell to $5.9 million in Q1 2026, from $8.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $55.4 million in Q1 2022 to a low of $5.9 million in Q1 2026.
• A 5-year average of $25.6 million and a median of $24.5 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 64.43% in 2022 and slumped 65.59% in 2025, its largest moves.
• Tracing COCP's Current Assets over 5 years: stood at $40.2 million in 2022, then decreased by 27.59% to $29.1 million in 2023, then tumbled by 60.19% to $11.6 million in 2024, then fell by 29.76% to $8.1 million in 2025, then declined by 26.99% to $5.9 million in 2026.
• Business Quant data shows COCP's Current Assets at $5.9 million in Q1 2026, $8.1 million in Q4 2025, and $8.8 million in Q3 2025.